Vaccine Is 'Insurance Policy' Against Emerging Viruses

February 2010
Bioworld Week;2/22/2010, Vol. 18 Issue 8, p1
The article provides information on Chikungunya virus that has been emerging to various patients in the U.S. It reveals that the illness was first described in 1952, which is characterized by fever and joint pain. It brings the fatality rates of other potential pandemic threats. According to researcher Gary Nabel, reported cases of Chikungunya virus have gone from zero in 2003 to several million since it was remerged in 2004.


Related Articles

  • Chikungunya Vaccine 'Insurance Policy' Against Emerging Viruses. Breindl, Anette // BioWorld Today;2/18/2010, Vol. 21 Issue 32, p1 

    The article reports on the development of a vaccine using virus-like particles (VLP) that were able to protect monkeys from the Chikungunya virus. According to Gary Nabel, director of the vaccine research at the National Institute of Allergy and Infectious Diseases, they found that serum from...

  • Universal Vaccine: 'End-Game' Pursuit to Counter Flu Pandemic. Young, Donna // BioWorld Today;12/14/2009, Vol. 20 Issue 239, p2 

    The article discusses the vaccine-related lessons learned from the 2009 H1N1 swine-origin influenza A pandemic. Francis Collins, director of the National Institutes of Health, claims that the pandemic emphasized the need to develop a vaccine in a faster manner. According to Gary Nabel, director...

  • One Step Closer to Universal Flu Vaccine. WEINTRAUB, KAREN // Discover;Jan/Feb2016, Vol. 37 Issue 1, p23 

    The article discusses the studies published in the journal "Nature Medicine" and "Science" in August 2015, which discovered a way for making universal flu vaccine, and also presents views of Gary Nabel, chief scientific officer at drugmaker Sanofi, on the issue.

  • An outbreak of yellow fever with concurrent chikungunya virus transmission in South Kordofan, Sudan, 2005. Gould, L. Hannah; Osman, Magdi S.; Farnon, Eileen C.; Griffith, Kevin S.; Godsey, Marvin S.; Karch, Said; Mulenda, Basimike; Kholy, Amgad El; Grandesso, Francesco; de Radigu├Ęs, Xavier; Brair, Maria-Emanuela; Briand, Sylvie; Tayeb, El Sadig Mahgoub El; Hayes, Edward B.; Zeller, Herve; Perea, William // Transactions of the Royal Society of Tropical Medicine & Hygiene;Dec2008, Vol. 102 Issue 12, p1247 

    Summary: From September through December 2005, an outbreak of hemorrhagic fever occurred in South Kordofan, Sudan. Initial laboratory test results identified IgM antibodies against yellow fever (YF) virus in patient samples, and a YF outbreak was declared on 14 November. To control the outbreak,...

  • Sanofi appoints Ebola response coordinator.  // BioSpectrum;Dec2014, Vol. 12 Issue 12, p12 

    The article announces the appointment of Gary J. Nabel as the Ebola response coordinator of pharmaceutical company Sanofi-Aventis SA.

  • Final battle. Day, Michael; Young, Emma // New Scientist;10/28/2000, Vol. 168 Issue 2262, p17 

    Reports on the development of a DNA vaccine for the Ebola virus. Difficulties of the development of the vaccine; Testing of a vaccine for Ebola by Gary Nabel; Outbreak of Ebola in Uganda; Idea that climate patterns are responsible for outbreaks of the disease.

  • Vaccines Stage a Comeback. Lemonick, Michael D.; Park, Alice // Time International (South Pacific Edition);1/21/2002, Issue 2, p52 

    Focuses on the comeback of vaccines in the United States after the September 11, 2001 terrorist attacks and the anthrax attacks. Role of vaccines as the great prevention success of modern medicine; History of conquering diseases; Idea that a new era of vaccine research has begun, according to...

  • A Two-Step Procedure Leads To A One-For-All Flu Vaccine. Breindl, Anette // BioWorld Today;7/16/2010, Vol. 21 Issue 136, p1 

    The article discusses a research study, published in the July 15, 2010 issue of "Sciencexpress," which showed the use of a two-step vaccination procedure to induce broadly neutralizing antibodies to various flu strains. According to Gary Nabel, a researcher at the National Institute for Allergy...

  • Mapping the future of HIV vaccines. Nabel, Gary J. // Nature Reviews Microbiology;Jul2007, Vol. 5 Issue 7, p482 

    Efforts to develop an HIV vaccine have been slower than expected, but significant progress has been made in recent years. Gary Nabel provides an update on this progress, and describes how the field is now poised to begin translating scientific understanding into improved vaccine candidates.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics